Announcement of Resolutions of the Sixth Extraordinary Meeting of the Ninth Board of Directors of Zhejiang Huahai Pharmaceutical Co., Ltd.
Stock abbreviation: Huahai Pharmaceutical Stock code: 600521 Announcement number: Lin 2025-113 Bond abbreviation: Huahai convertible bonds Bond code: 110076
Zhejiang Huahai Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Sixth Extraordinary Meeting of the Ninth Board of Directors
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and bear individual and joint liability for the authenticity, accuracy and completeness of its contents.
The sixth extraordinary meeting of the ninth board of directors of Zhejiang Huahai Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was held by communication at 15:00 pm on November 5, 2025 in the conference room on the fourth floor of the company. Nine directors should be present at the meeting, but nine directors actually attended the meeting, which complied with the quorum for convening a board meeting. The meeting was chaired by Mr. Li Hong, chairman of the company. The meeting procedures complied with the provisions of the Company Law and the Articles of Association, and the meeting was legal and valid. The meeting reviewed and passed the following resolutions:
1. The "Proposal on Not Revising the Conversion Price of "Huahai Convertible Bonds" Downward" was reviewed and approved.
Voting results: Agree: 9 votes; oppose: 0 votes; abstain: 0 votes.
For details, please refer to the "Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on Not Revising the Conversion Price of "Huahai Convertible Bonds" Downward" published by the company on November 6, 2025 in China Securities Journal, Shanghai Securities News, Securities Times, Securities Daily and the Shanghai Stock Exchange website (www.sse.com.cn).
Announcement is hereby made.
Board of Directors of Zhejiang Huahai Pharmaceutical Co., Ltd.
November 5, 2025
1/1